Adewale Oluseye Adisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adewale Oluseye Adisa has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
- Olalekan Olasehinde
Department of surgery, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
5 shared publications - Olukayode Adeolu Arowolo
Department of Surgery, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
5 shared publications Olusanya Adejuyigbe
Department of Surgery, Paediatric Surgery Unit, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
5 shared publications- Funmilola Olanike Wuraola
Department of surgery, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
4 shared publications - Olusegun Isaac Alatise
Department of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria
4 shared publications - Adewale Aderounmu
Department of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria
3 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023926
Barriers, facilitators and strategies for implementing on-site hospital solar power in low- and middle-income countries: a systematic review, global prioritisation survey and development of an implementation tool
Introduction: Healthcare facility power-outages in low- and middle-income countries (LMICs) are common and affect patient outcomes. Decentralised solar energy has the potential to reduce power-outages in healthcare settings, yet adoption in LMIC remains modest. This study aimed to identify and prioritise the barriers, facilitators and strategies of on-site healthcare facility solar power implementation. Methods: Methodology was conducted in three phases. In phase 1, a systematic review was completed to summarise barriers and facilitators to implementation of on-site solar power in LMIC healthcare facilities. Any qualitative or mixed-methods study relating to solar power installation from 2009 to 2024 in LMICs was eligible to be included. Barriers and facilitators were extracted from the identified studies and mapped to the Consolidated Framework for Implementation Research. In phase 2, the importance of these barrier and facilitator factors was contextually prioritised through an international survey of healthcare workers on a 5-point Likert scale. In phase 3, strategies were developed from these barrier and facilitator factors to create a solar implementation tool (SOLAR-IT). Results: In phase 1, out of a total of 3678 individual records, 28 studies were included in the systematic review, from which 19 barriers and 29 facilitators were identified. In phase 2, the global survey was completed by 260 participants from 47 LMICs. The barrier with the highest ranked importance was the upfront capital expenditure of solar panel installation, while the most important facilitator was to reduce the cost of solar panels through government intervention. In phase 3, 23 strategies were synthesised within four domains to create the SOLAR-IT. Conclusion: This study describes globally prioritised implementation factors and a strategy tool, which can enable teams to speed up implementation of on-site solar power in a time of extreme global need.
- 18 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023926
Open AccessBarriers, facilitators and strategies for implementing on-site hospital solar power in low- and middle-income countries: a systematic review, global prioritisation survey and development of an implementation tool
Introduction: Healthcare facility power-outages in low- and middle-income countries (LMICs) are common and affect patient outcomes. Decentralised solar energy has the potential to reduce power-outages in healthcare settings, yet adoption in LMIC remains modest. This study aimed to identify and prioritise the barriers, facilitators and strategies of on-site healthcare facility solar power implementation. Methods: Methodology was conducted in three phases. In phase 1, a systematic review was completed to summarise barriers and facilitators to implementation of on-site solar power in LMIC healthcare facilities. Any qualitative or mixed-methods study relating to solar power installation from 2009 to 2024 in LMICs was eligible to be included. Barriers and facilitators were extracted from the identified studies and mapped to the Consolidated Framework for Implementation Research. In phase 2, the importance of these barrier and facilitator factors was contextually prioritised through an international survey of healthcare workers on a 5-point Likert scale. In phase 3, strategies were developed from these barrier and facilitator factors to create a solar implementation tool (SOLAR-IT). Results: In phase 1, out of a total of 3678 individual records, 28 studies were included in the systematic review, from which 19 barriers and 29 facilitators were identified. In phase 2, the global survey was completed by 260 participants from 47 LMICs. The barrier with the highest ranked importance was the upfront capital expenditure of solar panel installation, while the most important facilitator was to reduce the cost of solar panels through government intervention. In phase 3, 23 strategies were synthesised within four domains to create the SOLAR-IT. Conclusion: This study describes globally prioritised implementation factors and a strategy tool, which can enable teams to speed up implementation of on-site solar power in a time of extreme global need.
- 22 August 2025
- Published by Springer Nature
- p. 159-171
Laparoscopic Cholecystectomy
- 1 August 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2500062
Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria
PURPOSE: To test the feasibility of a point-of-care (POC) real-time urine metabolomics test, evaluate its validity in diagnosing colorectal cancer (CRC) among at-risk patients, and assess the willingness of patients in Southwestern Nigeria to use and pay for the test. METHODS: This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were at-risk adults. The POC biosensor used a disposable chip and can be connected to a smart device using Bluetooth, and reported if the patient's urine contained metabolites consistent with CRC. We assessed validity of the test using sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV), and prespecified a specificity of 50% with a goal of ≥80% sensitivity to estimate the potential of the test to half the referrals to colonoscopy. Additionally, we assessed perception toward the test and willingness to uptake the urine test using structured questionnaires. RESULTS: The overall sensitivity, specificity, PPV, and NPV for all respondents were 91.18%, 81.58%, 81.58%, and 91.18% respectively, with an area under the receiver operating characteristic curve of 0.86. With specificity fixed at 50%, the overall sensitivity for all respondents was 94.5%, and all stratifications had sensitivity >90%. Overall, 70 (98.6%) were satisfied with the urine-based CRC screening, and respondents were willing to pay a mean amount of 8,008.20 Naira (about $5.2 US dollars) for the test. CONCLUSION: Our urine metabolite early diagnosis POC test met our predetermined criteria for success and had high acceptance rates among Nigerian patients, supporting a future multi-institutional implementation trial assessing our ability to scale up utilization.
- 1 August 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2500062
Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria
PURPOSE: To test the feasibility of a point-of-care (POC) real-time urine metabolomics test, evaluate its validity in diagnosing colorectal cancer (CRC) among at-risk patients, and assess the willingness of patients in Southwestern Nigeria to use and pay for the test. METHODS: This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were at-risk adults. The POC biosensor used a disposable chip and can be connected to a smart device using Bluetooth, and reported if the patient's urine contained metabolites consistent with CRC. We assessed validity of the test using sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV), and prespecified a specificity of 50% with a goal of ≥80% sensitivity to estimate the potential of the test to half the referrals to colonoscopy. Additionally, we assessed perception toward the test and willingness to uptake the urine test using structured questionnaires. RESULTS: The overall sensitivity, specificity, PPV, and NPV for all respondents were 91.18%, 81.58%, 81.58%, and 91.18% respectively, with an area under the receiver operating characteristic curve of 0.86. With specificity fixed at 50%, the overall sensitivity for all respondents was 94.5%, and all stratifications had sensitivity >90%. Overall, 70 (98.6%) were satisfied with the urine-based CRC screening, and respondents were willing to pay a mean amount of 8,008.20 Naira (about $5.2 US dollars) for the test. CONCLUSION: Our urine metabolite early diagnosis POC test met our predetermined criteria for success and had high acceptance rates among Nigerian patients, supporting a future multi-institutional implementation trial assessing our ability to scale up utilization.
- 18 January 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (3) , 187-188
Antibiotics versus appendicectomy in acute appendicitis: delay is not denial
- 18 January 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (3) , 187-188
Antibiotics versus appendicectomy in acute appendicitis: delay is not denial
- 18 November 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (4) , 630-636
Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry
Background: In Nigeria, gastric cancer is the 10th most common and 9th most deadly malignancy. The limited availability of robust data makes further characterizing it challenging. The objective of this study was to assess the presentation, and management of gastric cancer in Nigeria using an institutional cancer registry. Methods: We reviewed a prospective database of patients diagnosed with any gastric cancer at a single tertiary referral center over 15 years (2007–2022). Patients with suspected gastric cancer were surveyed for sociodemographics and then added to the institutional gastric cancer registry. Thereafter, periodic chart review and phone call was used to obtain investigation results, and survival data, respectively. Only patients with complete histopathology were included in analysis. Results: 138 patients met inclusion criteria (mean age 55.3 years, 68.8% male). Patients typically presented with weight loss (119, 86.2%) and anorexia (92, 66.7%). Blood work (132, 95.7%) and ultrasound (80, 57.9%) were the most common investigations. Most fully staged patients presented with metastatic disease (39, 90.2%). Patients underwent at least one treatment modality (109, 79.0%), and most 54 (49.5%) underwent both chemotherapy and surgery. Patients undergoing surgery usually had resection of their tumor (58, 67.4%). The median time of follow‐up was 45.6 months, and 51.4% (71) of patients were dead at that time point. Conclusion: Our gastric cancer database identified that most patients present with advanced disease and are undergoing at least one treatment modality. The next steps include initiatives to strengthen the quality of registry data, identify high‐risk patients, and provide timely treatment.
- 18 November 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (4) , 630-636
Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry
Background: In Nigeria, gastric cancer is the 10th most common and 9th most deadly malignancy. The limited availability of robust data makes further characterizing it challenging. The objective of this study was to assess the presentation, and management of gastric cancer in Nigeria using an institutional cancer registry. Methods: We reviewed a prospective database of patients diagnosed with any gastric cancer at a single tertiary referral center over 15 years (2007–2022). Patients with suspected gastric cancer were surveyed for sociodemographics and then added to the institutional gastric cancer registry. Thereafter, periodic chart review and phone call was used to obtain investigation results, and survival data, respectively. Only patients with complete histopathology were included in analysis. Results: 138 patients met inclusion criteria (mean age 55.3 years, 68.8% male). Patients typically presented with weight loss (119, 86.2%) and anorexia (92, 66.7%). Blood work (132, 95.7%) and ultrasound (80, 57.9%) were the most common investigations. Most fully staged patients presented with metastatic disease (39, 90.2%). Patients underwent at least one treatment modality (109, 79.0%), and most 54 (49.5%) underwent both chemotherapy and surgery. Patients undergoing surgery usually had resection of their tumor (58, 67.4%). The median time of follow‐up was 45.6 months, and 51.4% (71) of patients were dead at that time point. Conclusion: Our gastric cancer database identified that most patients present with advanced disease and are undergoing at least one treatment modality. The next steps include initiatives to strengthen the quality of registry data, identify high‐risk patients, and provide timely treatment.
- Open Access
- 25 July 2024
- Published by Springer Nature
A study to determine the rate of infection of wounds from abdominal operations across Nigeria
- 25 July 2024
- Published by Springer Nature
Open AccessA study to determine the rate of infection of wounds from abdominal operations across Nigeria
- Open Access
- 18 July 2024
- Published by Medknow in Journal of West African College of Surgeons
- Vol. 14 (4) , 432-434
Huge Choledochal Cyst in a 26-Year-Old Female: A Case Report
We present the case of a 26-year old woman who developed obstructive jaundice and massive abdominal swelling. Investigations revealed a huge choledochal cyst with obstructive pattern of hyperbilirubinaemia. She had exploratory laparotomy, drainage and excision of the choledochal cyst and Roux-en-Y hepaticojejunostomy. She has been followed up for 6 months in good clinical condition.
- 18 July 2024
- Published by Medknow in Journal of West African College of Surgeons
- Vol. 14 (4) , 432-434
Open AccessHuge Choledochal Cyst in a 26-Year-Old Female: A Case Report
We present the case of a 26-year old woman who developed obstructive jaundice and massive abdominal swelling. Investigations revealed a huge choledochal cyst with obstructive pattern of hyperbilirubinaemia. She had exploratory laparotomy, drainage and excision of the choledochal cyst and Roux-en-Y hepaticojejunostomy. She has been followed up for 6 months in good clinical condition.
- 1 July 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2300460
Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review
PURPOSE: Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women. METHODS: This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables. RESULTS: The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively. CONCLUSION: This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.
- 1 July 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2300460
Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review
PURPOSE: Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women. METHODS: This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables. RESULTS: The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively. CONCLUSION: This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.
- Open Access
- 21 May 2024
- Published by Elsevier in The Lancet Global Health
- Vol. 12 (7) , e1073-e1074
Geospatial disparities in breast cancer care in sub-Saharan Africa: time to act
- 21 May 2024
- Published by Elsevier in The Lancet Global Health
- Vol. 12 (7) , e1073-e1074
Open AccessGeospatial disparities in breast cancer care in sub-Saharan Africa: time to act
- Open Access
- 11 October 2023
- Published by Wiley in World Journal of Surgery
- Vol. 47 (12) , 3042-3050
A Prospective, Observational Cost Comparison of Laparoscopic and Open Appendicectomy in Three Tertiary Hospitals in Nigeria
Background: The clinical benefits of laparoscopic appendicectomy are well recognized over open appendicectomy. However, laparoscopic procedures are not frequently conducted in many low‐and middle‐income countries (LMICs) for several reasons, including perceived higher costs. The aim of this study was to assess the feasibility and cost of laparoscopic appendicectomy compared to open appendicectomy in Nigeria.Methods: A multicenter, prospective, cohort study among patients undergoing appendicectomy was conducted at three tertiary hospitals in Nigeria. Data were collected from October 2020 to February 2022 and analyses compared the average healthcare costs at 30 days after surgery. Quantile regression was conducted to identify variables that had an impact on the costs, reported in Nigerian Naira (Naira) and US dollars ($), with standard deviations (SD).Findings: This study included 105 patients, of which 39 had laparoscopic appendicectomy and 66 had open appendicectomy. The average healthcare cost of laparoscopic appendicectomy (147,562 Naira (SD: 97,130) or $355 (SD: 234)) was higher than open appendicectomy (113,556 Naira (SD: 88,559) or $273 (SD: 213)). The average time for return to work was shorter with laparoscopic than open appendicectomy (mean: 8 days vs. 14 days). At the average daily income of $5.06, laparoscopic appendicectomy was associated with 9778 Naira or $24 cost savings in return to work. Further, 5.1% of laparoscopic appendicectomy patients had surgical site infections compared to 22.7% for open appendicectomy. Regression analysis results showed that laparoscopic appendicectomy was associated with $14 higher costs than open appendicectomy, albeit non‐significant (p = 0.53).Interpretation: Despite selection bias in this real‐world study, laparoscopic appendicectomy was associated with a slightly higher overall cost, a lower societal cost, a lower infection rate, and a faster return to work, compared to open appendicectomy. It is technically and financially feasible, and its provision in Nigeria should be expanded.
- 11 October 2023
- Published by Wiley in World Journal of Surgery
- Vol. 47 (12) , 3042-3050
Open AccessA Prospective, Observational Cost Comparison of Laparoscopic and Open Appendicectomy in Three Tertiary Hospitals in Nigeria
Background: The clinical benefits of laparoscopic appendicectomy are well recognized over open appendicectomy. However, laparoscopic procedures are not frequently conducted in many low‐and middle‐income countries (LMICs) for several reasons, including perceived higher costs. The aim of this study was to assess the feasibility and cost of laparoscopic appendicectomy compared to open appendicectomy in Nigeria.Methods: A multicenter, prospective, cohort study among patients undergoing appendicectomy was conducted at three tertiary hospitals in Nigeria. Data were collected from October 2020 to February 2022 and analyses compared the average healthcare costs at 30 days after surgery. Quantile regression was conducted to identify variables that had an impact on the costs, reported in Nigerian Naira (Naira) and US dollars ($), with standard deviations (SD).Findings: This study included 105 patients, of which 39 had laparoscopic appendicectomy and 66 had open appendicectomy. The average healthcare cost of laparoscopic appendicectomy (147,562 Naira (SD: 97,130) or $355 (SD: 234)) was higher than open appendicectomy (113,556 Naira (SD: 88,559) or $273 (SD: 213)). The average time for return to work was shorter with laparoscopic than open appendicectomy (mean: 8 days vs. 14 days). At the average daily income of $5.06, laparoscopic appendicectomy was associated with 9778 Naira or $24 cost savings in return to work. Further, 5.1% of laparoscopic appendicectomy patients had surgical site infections compared to 22.7% for open appendicectomy. Regression analysis results showed that laparoscopic appendicectomy was associated with $14 higher costs than open appendicectomy, albeit non‐significant (p = 0.53).Interpretation: Despite selection bias in this real‐world study, laparoscopic appendicectomy was associated with a slightly higher overall cost, a lower societal cost, a lower infection rate, and a faster return to work, compared to open appendicectomy. It is technically and financially feasible, and its provision in Nigeria should be expanded.